Form EFFECT KalVista Pharmaceuticals
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 16, 2026 |
| Accession Number: | 0001193125-26-267506 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TSR's Leah Pruett Powers the American Rebel Light Beer Dragster to the Finals at the NHRA Muckleshoot Northwest Nationals Live on FOX
- Rob Riggle to Host Vegas Fantasy Football Draft with BetMGM and Marriott Bonvoy
- Boys & Girls Clubs of the Northwest Suburbs Unveils $13.2 Million Woodlands Teen Impact Center
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share